title: Update in palliative management of hormone refractory cancer of prostate.
abstract: Hormone refractory prostate cancer (HRPC) is an incurable disease and as in the pressure sensitive adhesive era the median survival of patients is increasing, these men increasingly develop symptomatic problems as a result of advanced local and or metastatic disease during their progression to death. Recently, it has been shown that it is possible to improve survival in this group of patients with use of chemotherapy which reinforces the need of better options in palliative care. We discus the various clinical problems (Part I) and treatment options of palliative care (Part II) and try to formulate an action plan in this review.
authors.affiliation: Department of Urology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
authors.forename: Pratipal
authors.initials: P
authors.lastname: Singh
authors.forename: Aneesh
authors.initials: A
authors.lastname: Srivastava
references.citation: Cancer. 2004 Mar 1;100(5):892-9
references.pmid: 14983482
references.citation: Radiother Oncol. 1994 Apr;31(1):33-40
references.pmid: 7518932
references.citation: Radiology. 1989 Oct;173(1):225-9
references.pmid: 2675185
references.citation: J Clin Oncol. 2003 Apr 1;21(7):1232-7
references.pmid: 12663709
references.citation: J Neurosurg. 1983 Jul;59(1):111-8
references.pmid: 6864265
references.citation: J Urol. 2004 Apr;171(4):1525-8
references.pmid: 15017212
references.citation: Ann R Coll Surg Engl. 2003 Nov;85(6):382-5
references.pmid: 14629877
references.citation: Eur J Nucl Med Mol Imaging. 2002 Apr;29(4):494-8
references.pmid: 11914887
references.citation: Prog Clin Biol Res. 1987;243B:479-85
references.pmid: 2443925
references.citation: J Natl Cancer Inst. 2002 Oct 2;94(19):1458-68
references.pmid: 12359855
references.citation: Acta Chir Belg. 1998 Dec;98(6):255-60
references.pmid: 9922813
references.citation: Br J Urol. 1992 May;69(5):530-3
references.pmid: 1320441
references.citation: Urol Clin North Am. 1991 Feb;18(1):145-52
references.pmid: 1992568
references.citation: J Nucl Med. 1975 Nov;16(11):986-9
references.pmid: 810549
references.citation: Br J Urol. 1994 Nov;74(5):642-5
references.pmid: 7827817
references.citation: J Urol. 2002 Sep;168(3):1005-7
references.pmid: 12187209
references.citation: J Neurooncol. 1995;23(2):135-47
references.pmid: 7543940
references.citation: Prostate. 1997 May 15;31(3):153-60
references.pmid: 9167766
references.citation: Pharmacotherapy. 1999 Feb;19(2):223-7
references.pmid: 10030773
references.citation: Cancer. 1994 Nov 1;74(9):2516-9
references.pmid: 7923009
references.citation: Cancer. 1982 Sep 1;50(5):893-9
references.pmid: 6178497
references.citation: J Urol. 1976 Jul;116(1):1-7
references.pmid: 778399
references.citation: Urology. 1991 Dec;38(6):526-8
references.pmid: 1746080
references.citation: Br J Urol. 1994 Nov;74(5):559-65
references.pmid: 7530118
references.citation: Anesthesiology. 1996 May;84(5):1243-57
references.pmid: 8624021
references.citation: J Urol. 2001 Mar;165(3):871-5
references.pmid: 11176489
references.citation: J Urol. 1996 Aug;156(2 Pt 1):526-31
references.pmid: 8683730
references.citation: J Urol. 2001 Dec;166(6):2023-31
references.pmid: 11696699
references.citation: Br J Urol. 1992 Dec;70(6):643-7
references.pmid: 1283104
references.citation: Br J Urol. 1995 Jun;75(6):782-5
references.pmid: 7613836
references.citation: Radiother Oncol. 1986 Aug;6(4):247-55
references.pmid: 3775071
references.citation: Curr Probl Cancer. 1986 Mar;10(3):117-68
references.pmid: 3514130
references.citation: Int J Radiat Oncol Biol Phys. 1989 Dec;17(6):1281-5
references.pmid: 2480941
references.citation: Cancer. 1993 Feb 15;71(4):1309-12
references.pmid: 8382106
references.citation: Urology. 1986 Oct;28(4):280-7
references.pmid: 3765236
references.citation: Eur J Surg. 1994 Oct;160(10):535-42
references.pmid: 7849154
references.citation: N Engl J Med. 2004 Oct 7;351(15):1502-12
references.pmid: 15470213
references.citation: Cancer. 1997 Oct 15;80(8 Suppl):1588-94
references.pmid: 9362426
references.citation: JAMA. 1995 Aug 2;274(5):420-4
references.pmid: 7542352
references.citation: Urology. 1974 May;3(5):562-4
references.pmid: 4830631
references.citation: J Urol. 2004 Feb;171(2 Pt 1):668-71
references.pmid: 14713783
references.citation: Eur Urol. 1993;24 Suppl 2:118-21
references.pmid: 8262116
references.citation: Ann Oncol. 2005 Apr;16(4):579-84
references.pmid: 15734776
references.citation: Md Med J. 1991 Feb;40(2):113-5
references.pmid: 1997794
references.citation: Urology. 1986 Nov;28(5):364-9
references.pmid: 3787893
references.citation: Qual Life Res. 2006 Oct;15(8):1297-306
references.pmid: 16830258
references.citation: Neuroscience. 2000;98(3):585-98
references.pmid: 10869852
references.citation: Semin Surg Oncol. 1995 Jan-Feb;11(1):50-9
references.pmid: 7754276
references.citation: J Urol. 1974 Jun;111(6):799-802
references.pmid: 4830885
references.citation: J Neurosurg. 1980 Dec;53(6):741-8
references.pmid: 7441333
references.citation: Scand J Urol Nephrol. 2001 Sep;35(4):288-94
references.pmid: 11676354
references.citation: Urol Clin North Am. 1999 May;26(2):375-89
references.pmid: 10361560
references.citation: J Pain Symptom Manage. 1992 Feb;7(2):110-6
references.pmid: 1573284
references.citation: Urology. 1997 Apr;49(4A Suppl):46-53
references.pmid: 9111614
references.citation: Curr Treat Options Neurol. 1999 Nov;1(5):409-416
references.pmid: 11096725
references.citation: J Urol. 2000 Oct;164(4):1248-53
references.pmid: 10992374
references.citation: Cancer. 1997 Feb 1;79(3):545-50
references.pmid: 9028366